Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Another beta3-adrenergic agent added to the BMS pipeline

Aug. 28, 1998

Ergo Science submits amendment to Ergoset NDA

Aug. 28, 1998

Bristol-Myers Squibb program on beta3-adrenoceptor agonists outlined at ACS

Aug. 27, 1998

Fuji Chemical patents new treatment for kidney disease in diabetic patients

Aug. 27, 1998

Selective alphav/beta3 integrin receptor antagonists from DuPont Pharmaceuticals

Aug. 27, 1998

Further international approvals, product launches announced for Muse

Aug. 27, 1998

Advisory committee recommends European approval for Viagra

Aug. 26, 1998

Bio-Technology General in-licenses PEG-uricase for development

Aug. 26, 1998

Antidiabetes drug from Amylin enters phase I clinical study

Aug. 26, 1998

Lilly describes promising beta3-adrenoceptor agonist at ACS meeting

Aug. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Makary out at the FDA
BioWorld
U.S. President Donald Trump ended days of rumors and speculation when he confirmed May 12 that Marty Makary is resigning as FDA commissioner. Speaking with...